NCT02717039View on ClinicalTrials.gov

Pharmacogenomics of Heparin-Induced Thrombocytopenia

RecruitingOBSERVATIONAL

Enrollment

125

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Heparin-induced Thrombocytopenia

Interventions

PROCEDURE

Blood Draw

A one time blood draw of 150 milliliters will be performed using a vein in the participants arm. Existing venous access will be used for the blood draw in preference of new venipuncture.

Trial Locations (1)

85721

RECRUITING

Banner University Medical Center - Tucson, Tucson

All Listed Sponsors

collaborator

American College of Clinical Pharmacy

OTHER

lead

University of Arizona

OTHER

NCT02717039 - Pharmacogenomics of Heparin-Induced Thrombocytopenia | Biotech Hunter | Biotech Hunter